Clinical Trial Update: A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating AZD1390 in combination with stereotactic body radiotherapy (SBRT) for adults with metastatic solid tumors. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma
• Solid Tumor

Drugs mentioned

• AZD1390

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING